We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KSS icon
626
Kohl's
KSS
$2.03B
$521K 0.01%
13,091
+2,494
+24% +$102K
JD icon
627
JD.com
JD
$40.8B
$492K 0.01%
15,800
-2,000
-11% -$58.9K
DRI icon
628
Darden Restaurants
DRI
$22.5B
$486K 0.01%
5,805
– –
ROST icon
629
Ross Stores
ROST
$76.6B
$484K 0.01%
7,342
-18,740
-72% -$1.25M
LW icon
630
Lamb Weston
LW
$6.82B
$460K 0.01%
10,927
-3,235
-23% -$128K
SNA icon
631
Snap-on
SNA
$20.9B
$458K 0.01%
2,716
-1,019
-27% -$175K
PDCO
632
DELISTED
Patterson Companies, Inc.
PDCO
$458K 0.01%
10,130
– –
RNAC icon
633
Cartesian Therapeutics
RNAC
$232M
$444K 0.01%
+1,033
New +$435K
STAA icon
634
STAAR Surgical
STAA
$1.16B
$441K 0.01%
+45,000
New +$449K
FFIV icon
635
F5
FFIV
$22.1B
$428K 0.01%
3,000
-29,827
-91% -$4.26M
NTES icon
636
NetEase
NTES
$76.5B
$426K 0.01%
7,500
– –
TEVA icon
637
Teva Pharmaceuticals
TEVA
$35.9B
$420K 0.01%
13,076
-42,064
-76% -$1.44M
LOGM
638
DELISTED
LogMein, Inc.
LOGM
$407K 0.01%
+4,171
New +$415K
INVN
639
DELISTED
Invensense Inc
INVN
$398K 0.01%
31,518
-63,482
-67% -$791K
BALL icon
640
Ball Corp
BALL
$17B
$359K 0.01%
9,680
+3,918
+68% +$146K
NI icon
641
NiSource
NI
$22.4B
$341K 0.01%
14,336
-111,065
-89% -$2.54M
ITUB icon
642
Itaú Unibanco
ITUB
$91.3B
$334K 0.01%
57,052
– –
RAD
643
DELISTED
Rite Aid Corporation
RAD
$332K 0.01%
3,909
+835
+27% +$101K
TRIP icon
644
TripAdvisor
TRIP
$1.59B
$316K 0.01%
7,314
+2,821
+63% +$134K
VRN
645
DELISTED
Veren
VRN
$315K 0.01%
29,198
+13,024
+81% +$151K
DNOW icon
646
DNOW Inc
DNOW
$2.63B
$293K 0.01%
17,285
– –
CSOD
647
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$288K 0.01%
+7,400
New +$305K
ASRT
648
DELISTED
Assertio
ASRT
$267K 0.01%
354
-834
-70% -$845K
CVE icon
649
Cenovus Energy
CVE
$54.6B
$252K ﹤0.01%
22,361
+2,200
+11% +$29.6K
BRK.A icon
650
Berkshire Hathaway Class A
BRK.A
$1.07T
$250K ﹤0.01%
1
– –
24 25
26
27 28

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.